62/100B416.68
USD
0.61
(0.15%)
Market Closed
Last updated: · Delayed 15 min
BeiGene market capWhat is market capitalization? Market cap is what the stock market values a whole company at: its share price times the number of its shares outstanding.
BeiGene's market cap is 44.53B USD: 106,858,473 shares outstanding at today's price of 416.68.
- Today
- 44.53B
- Average, 5 years
- 25.48B
- Low, 5 years
- 12.40B
- High, 5 years
- 48.23B
Market cap = price × shares outstanding = 416.68 × 106.86M = 44.53B
Each day's closing price times the shares outstanding in the last 10-Q or 10-K filed by then (the quarter's basic share count, adjusted for splits); from the latest count on, the shares outstanding now.
Market cap by year and by quarter
| Fiscal year | Period ending | Market cap |
|---|---|---|
| Today | 44.53B | |
| FY2025 | 31 Dec 2025 | 33.13B |
| FY2024 | 31 Dec 2024 | 19.45B |
| FY2023 | 31 Dec 2023 | 18.83B |
| FY2022 | 31 Dec 2022 | 22.68B |
| FY2021 | 31 Dec 2021 | 25.14B |
| FY2020 | 31 Dec 2020 | 21.57B |
| FY2019 | 31 Dec 2019 | 9.95B |
| FY2018 | 31 Dec 2018 | 7.78B |
| FY2017 | 31 Dec 2017 | 4.08B |
| FY2016 | 31 Dec 2016 | 942.61M |
| FY2015 | 31 Dec 2015 | 892.57M |
| FY2014 | 31 Dec 2014 | 1.49B |
| FY2013 | 31 Dec 2013 | 149.13M |
| Quarter | Period ending | Market cap |
|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 41.61B |
| Q2 FY2026 | 30 Jun 2026 | 31.80B |
| Q1 FY2026 | 31 Mar 2026 | 32.95B |
| Q4 FY2025 | 31 Dec 2025 | 33.13B |
| Q3 FY2025 | 30 Sept 2025 | 37.55B |
| Q2 FY2025 | 30 Jun 2025 | 26.28B |
| Q1 FY2025 | 31 Mar 2025 | 29.10B |
| Q4 FY2024 | 31 Dec 2024 | 19.63B |
| Q3 FY2024 | 30 Sept 2024 | 23.51B |
| Q2 FY2024 | 30 Jun 2024 | 15.17B |
| Q1 FY2024 | 31 Mar 2024 | 16.60B |
| Q4 FY2023 | 31 Dec 2023 | 18.77B |
| Q3 FY2023 | 30 Sept 2023 | 18.83B |
| Q2 FY2023 | 30 Jun 2023 | 18.66B |
| Q1 FY2023 | 31 Mar 2023 | 22.45B |
| Q4 FY2022 | 31 Dec 2022 | 22.82B |
| Q3 FY2022 | 30 Sept 2022 | 13.95B |
| Q2 FY2022 | 30 Jun 2022 | 16.64B |
| Q1 FY2022 | 31 Mar 2022 | 19.32B |
| Q4 FY2021 | 31 Dec 2021 | 25.75B |
| Q3 FY2021 | 30 Sept 2021 | 33.67B |
| Q2 FY2021 | 30 Jun 2021 | 31.52B |
| Q1 FY2021 | 31 Mar 2021 | 31.83B |
| Q4 FY2020 | 31 Dec 2020 | 23.47B |
| Q3 FY2020 | 30 Sept 2020 | 25.32B |
| Q2 FY2020 | 30 Jun 2020 | 14.64B |
| Q1 FY2020 | 31 Mar 2020 | 9.52B |
| Q4 FY2019 | 31 Dec 2019 | 10.06B |
| Q3 FY2019 | 30 Sept 2019 | 7.36B |
| Q2 FY2019 | 30 Jun 2019 | 7.60B |
| Q1 FY2019 | 31 Mar 2019 | 8.23B |
| Q4 FY2018 | 31 Dec 2018 | 8.33B |
| Q3 FY2018 | 30 Sept 2018 | 9.97B |
| Q2 FY2018 | 30 Jun 2018 | 8.26B |
| Q1 FY2018 | 31 Mar 2018 | 8.67B |
| Q4 FY2017 | 31 Dec 2017 | 4.45B |
| Q3 FY2017 | 30 Sept 2017 | 4.36B |
| Q2 FY2017 | 30 Jun 2017 | 1.79B |
| Q1 FY2017 | 31 Mar 2017 | 1.45B |
| Q4 FY2016 | 31 Dec 2016 | 1.20B |
| Q3 FY2016 | 30 Sept 2016 | 1.01B |
| Q2 FY2016 | 30 Jun 2016 | 980.53M |
| Q1 FY2016 | 31 Mar 2016 | 944.09M |
| Q4 FY2015 | 31 Dec 2015 | 892.57M |
| Q3 FY2015 | 30 Sept 2015 | 1.52B |
| Q2 FY2015 | 30 Jun 2015 | 1.52B |
| Q1 FY2015 | 31 Mar 2015 | 1.52B |
| Q4 FY2014 | 31 Dec 2014 | 1.52B |
| Q3 FY2014 | 30 Sept 2014 | 1.52B |
| Q2 FY2014 | 30 Jun 2014 | 15.84M |
| Q1 FY2014 | 31 Mar 2014 | 15.84M |
See also:P/S ratio,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about BeiGene's market cap
Source: Financial Modeling Prep